What is the equivalent telmisartan dose for a patient taking losartan 100 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Losartan 100 mg Equivalent Dose for Telmisartan

Telmisartan 80 mg once daily is the equivalent dose to losartan 100 mg once daily.

Dose Equivalency Rationale

The FDA-approved dosing ranges establish that:

  • Losartan: 50-100 mg once daily (maximum dose) 1
  • Telmisartan: 20-80 mg once daily (maximum dose) 2

This creates an approximate 1.25:1 ratio (losartan:telmisartan) at maximum doses, meaning losartan 100 mg corresponds to telmisartan 80 mg.

Supporting Clinical Evidence

Multiple head-to-head trials confirm telmisartan's superior or equivalent efficacy at lower milligram doses:

  • Telmisartan 80 mg demonstrated greater blood pressure reduction than losartan 100 mg in titration-to-response studies. The meta-analysis showed telmisartan 40/80 mg reduced last 6-hour mean ambulatory DBP by 6.6 mmHg vs 5.1 mmHg with losartan 50/100 mg (p<0.01) 3. This superior efficacy during the critical trough period (hours 18-24 post-dose) indicates telmisartan 80 mg provides better 24-hour coverage than losartan 100 mg.

  • A randomized double-blind study found telmisartan 80 mg achieved a 79.3% DBP response rate compared to 65.3% with losartan 100 mg (p=0.008) 4. Mean trough blood pressure reductions were significantly greater with telmisartan (SBP 12.5 vs 9.4 mmHg, DBP 10.9 vs 9.3 mmHg).

  • When combined with hydrochlorothiazide 12.5 mg, telmisartan 80 mg/HCTZ produced 2.5 mmHg greater DBP reduction than losartan 50 mg/HCTZ during the last 6 hours of dosing (p<0.001) 5.

Clinical Considerations

Telmisartan offers pharmacokinetic advantages that explain its greater potency per milligram:

  • Longer half-life (24 hours vs 6-9 hours for losartan)
  • More sustained AT1 receptor blockade throughout the 24-hour dosing interval
  • No dependence on hepatic conversion to active metabolite (unlike losartan)

Practical conversion approach:

  • Switch directly from losartan 100 mg to telmisartan 80 mg once daily
  • Recheck blood pressure in 2-4 weeks
  • Both medications have similar safety profiles with comparable adverse event rates (23.2% vs 22.9%) 4

Important caveat: While telmisartan 80 mg is the dose-equivalent replacement, clinical trials consistently show it provides superior blood pressure control compared to losartan 100 mg, particularly during the last 6 hours of the dosing interval when trough effects matter most for cardiovascular protection 3, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.